Is Atara Biotherapeutics Stock a Buy?

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) is a biotech company that has developed allogeneic, or donor-derived, Epstein-Barre Virus (EBV) T-cell treatments for …